Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4078542
Max Phase: Preclinical
Molecular Formula: C68H118N22O8S
Molecular Weight: 1403.90
Molecule Type: Small molecule
Associated Items:
ID: ALA4078542
Max Phase: Preclinical
Molecular Formula: C68H118N22O8S
Molecular Weight: 1403.90
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)NC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=O)N[C@H](CNC(=O)N[C@@H](CCCCN)CNC(=S)N[C@H](CCC(N)=O)C(C)C)Cc1c[nH]c2ccccc12)C(C)C)Cc1c[nH]c2ccccc12)C(C)C
Standard InChI: InChI=1S/C68H118N22O8S/c1-42(2)55(26-27-60(72)91)90-68(99)81-37-50(21-15-18-30-71)85-61(92)77-38-51(31-46-33-73-56-24-11-9-22-53(46)56)86-62(93)75-35-48(19-13-16-28-69)83-64(95)79-40-58(43(3)4)88-66(97)78-39-52(32-47-34-74-57-25-12-10-23-54(47)57)87-63(94)76-36-49(20-14-17-29-70)84-65(96)80-41-59(44(5)6)89-67(98)82-45(7)8/h9-12,22-25,33-34,42-45,48-52,55,58-59,73-74H,13-21,26-32,35-41,69-71H2,1-8H3,(H2,72,91)(H2,75,86,93)(H2,76,87,94)(H2,77,85,92)(H2,78,88,97)(H2,79,83,95)(H2,80,84,96)(H2,81,90,99)(H2,82,89,98)/t48-,49-,50-,51-,52-,55+,58+,59+/m0/s1
Standard InChI Key: DIWHRSBTFARDPW-ZAWIMVIBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1403.90 | Molecular Weight (Monoisotopic): 1402.9224 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Antunes S, Corre JP, Mikaty G, Douat C, Goossens PL, Guichard G.. (2017) Effect of replacing main-chain ureas with thiourea and guanidinium surrogates on the bactericidal activity of membrane active oligourea foldamers., 25 (16): [PMID:28687228] [10.1016/j.bmc.2017.04.040] |
Source(1):